Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/43071
Campo DC Valoridioma
dc.contributor.authorBetancor-Hernández, Eva
dc.contributor.authorPérez-Machín, Rubén
dc.contributor.authorHenríquez-Hernández, Luis
dc.contributor.authorMateos-Díaz, Carlos
dc.contributor.authorNovoa-Mogollón, Javier
dc.contributor.authorFernández-Pérez, Leandro
dc.date.accessioned2018-11-21T12:22:45Z-
dc.date.available2018-11-21T12:22:45Z-
dc.date.issued2003
dc.identifier.issn0960-0760
dc.identifier.urihttp://hdl.handle.net/10553/43071-
dc.description.abstractSteroid-binding proteins unrelated to the classical nuclear receptors have been proposed to play a role in non-genomic actions of the17alpha-alkylated testosterone derivative (17alpha-AA) stanozolol (ST). We have previously reported that male rat liver endoplasmic reticulum contains two steroid-binding sites associated with high molecular mass oligomeric proteins: (1) the ST-binding protein (STBP); and (2) the low-affinity glucocorticoid-binding protein (LAGS). To further explore the role of LAGS on the mechanism of action of ST, we have now studied: (1) the interaction of ST and its hydroxylated metabolites with solubilized LAGS and the cytosolic glucocorticoid receptor (GR); and (2) the effects of hormones on the capability of STBP to bind ST. We found that, unlike 17alpha-methyltestosterone, neither ST nor its hydroxylated metabolites bind to GR. However, the 16beta-hydroxylation of ST significantly increases the capability of LAGS to bind ST. Interestingly, 3'-hydroxylation of ST abrogates the capability of LAGS to bind ST. ST (k(i) = 30 nM) and 16beta-hydroxystanozolol (ki = 13 nM) bind with high affinity to LAGS, and are capable of accelerating the rate of dissociation of previously bound dexamethasone from the LAGS. STBP and LAGS are strongly induced by ethinylestradiol. However, unlike STBP, LAGS is regulated by thyroid hormones and growth hormone, which proves that these steroid-binding activities are associated with different binding sites. These findings seem to suggest a novel mechanism for ST whereby membrane-associated glucocorticoid-binding activity is targeted by the 16beta-hydroxylated metabolite of ST. ST and its 16beta-hydroxylated metabolite modulate glucocorticoid activity in the liver through negative allosteric modulation of LAGS, with the result of this interaction an effective increase in classical GR-signaling by increasing glucocorticoid availability to the cytosolic GR. (C) 2003 Elsevier Ltd. All rights reserved.
dc.publisher0960-0760
dc.relation.ispartofJournal of Steroid Biochemistry and Molecular Biology
dc.sourceJournal of Steroid Biochemistry and Molecular Biology[ISSN 0960-0760],v. 87, p. 253-264
dc.subject.otherAnabolic-Steroid Stanozolol
dc.subject.otherMembrane-Proteins
dc.subject.otherPlasma-Membranes
dc.subject.otherSkeletal-Muscle
dc.subject.otherLipid Rafts
dc.subject.otherSites
dc.subject.otherMicrosomes
dc.subject.otherAndrogen
dc.subject.otherReceptors
dc.subject.otherDexamethasone
dc.titlePhotoaffinity labeling identification of thyroid hormone-regulated glucocorticoid-binding peptides in rat liver endoplasmic reticulum: An oligomeric protein with high affinity for 16β-hydroxylated stanozolol
dc.typeinfo:eu-repo/semantics/Articlees
dc.typeArticlees
dc.identifier.doi10.1016/j.jsbmb.2003.09.009
dc.identifier.scopus17744404731-
dc.identifier.isi000188372700005
dc.contributor.authorscopusid6505712316
dc.contributor.authorscopusid6505576075
dc.contributor.authorscopusid15829708200
dc.contributor.authorscopusid6503885823
dc.contributor.authorscopusid12786120600
dc.contributor.authorscopusid6506777525
dc.description.lastpage264
dc.description.firstpage253
dc.relation.volume87
dc.type2Artículoes
dc.contributor.daisngid11824278
dc.contributor.daisngid5160442
dc.contributor.daisngid465624
dc.contributor.daisngid6799819
dc.contributor.daisngid6408279
dc.contributor.daisngid795544
dc.contributor.wosstandardWOS:Betancor-Hernandez, E
dc.contributor.wosstandardWOS:Perez-Machin, R
dc.contributor.wosstandardWOS:Henriquez-Hernandez, L
dc.contributor.wosstandardWOS:Mateos-Diaz, C
dc.contributor.wosstandardWOS:Novoa-Mogollon, J
dc.contributor.wosstandardWOS:Fernandez-Perez, L
dc.date.coverdateEnero 2003
dc.identifier.ulpgces
dc.description.jcr2,596
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Medio Ambiente y Salud-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-9958-9382-
crisitem.author.orcid0000-0003-3237-0316-
crisitem.author.orcid0000-0001-7802-465X-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameBetancor Hernández, Eva Del Carmen-
crisitem.author.fullNameHenríquez Hernández, Luis Alberto-
crisitem.author.fullNameFernández Pérez, Leandro Francisco-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

2
actualizado el 15-dic-2024

Citas de WEB OF SCIENCETM
Citations

2
actualizado el 15-dic-2024

Visitas

22
actualizado el 08-jul-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.